Sastasundar Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sastasundar Ventures Limited has informed the stock exchanges that its Board of Directors will meet on Friday, February 6, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. This is a standard regulatory intimation under SEBI Listing Regulations. The company also reminded that the trading window for dealing in its securities remains closed and will stay shut until 48 hours after the results are announced. No financial numbers or specific business decisions are disclosed in this notice.
This is a routine advance notice ahead of the Q3 FY26 earnings announcement, so expect the actual numbers and any commentary on December 6, 2026. Until results are out, there is no new fundamental information for shareholders to act on — the trading window closure just means insiders cannot trade until after results are declared.